An independent watchdog of the Global Fund and publisher of Global Fund Observer

Global Fund Overview

Global AIDS is the worst public health crisis that mankind has faced in 700 years, and no end to its escalation is in sight. TB and malaria also kill millions annually.

In 2001 UN Secretary-General Kofi Annan proposed a Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Fund started operations in January 2002. The Fund is not part of the UN. It is run by an innovative public-private board made up of developed- and developing-country governments, the private sector, foundations, non-governmental organizations (NGOs), and people living with the three diseases.

The Global Fund raises and disburses billions of dollars every year. It aspires, in effect, to be the world's largest fund-raising operation and the world's largest grant-making operation. The Fund has an excellent web site at www.theglobalfund.org.

Since its inception, the Global Fund has approved 717 grants, of which 442 have been extended to Phase 2 (Years 3 and beyond).

The most recent agreement for a new grant was signed on 16 August 2010, providing an initial amount of $12,331,525 for a project in South Africa.

The most recent agreement to extend a grant beyond its initial 2-year period was signed on 16 August 2010, providing $3,412,811 for a TB project in Multicountry Western Pacific.

Funding has been distributed by disease component and by region as follows:

Approved funding by disease component
HIV/AIDS $10.50 billion
Malaria $5.33 billion
TB $3.22 billion
HIV/TB $0.23 billion
HSS $0.09 billion
Integrated $0.00 billion
Approved funding by region
East Africa $4.76 billion
West and Central Africa $3.16 billion
Southern Africa $3.05 billion
East Asia and the Pacific $2.80 billion
South Asia $1.68 billion
Eastern Europe and Central Asia $1.44 billion
Latin America and the Caribbean $1.40 billion
North Africa and the Middle East $1.08 billion

For details of individual grants, country-by-country information, indications of which grants are ahead of or behind schedule, and more, visit the Grant Details, Analysis and Evaluation pages on this site.